US › Healthcare

Burning Rock Biotech Ltd (BNR)

US · Healthcare · Diagnostics & Research

$13.42+1.28%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

$134.9M

Revenue YoY

-9.2%

Net profit

$-18.4M

EPS

$-0.20

Net margin

-13.7%

Key statistics

Market cap

$135.3M

Forward P/E

0.0

P/B

1.50

Book value

$6.85

EPS (TTM)

$-0.80

52-week high

$41.72

52-week low

$6.79

50-day MA

$13.26

200-day MA

$16.16

Beta

1.52

Analyst view

with an average price target of $4.03.

Shareholding

Insiders

4.03%

Institutions

46.87%

Largest institutional holders

Fund	Stake
Kynam Capital Management, LP	11.74%
CRCM LP	4.02%
Renaissance Technologies Corp	0.50%
Morgan Stanley - Brokerage Accounts	0.41%
Amova Asset Management Americas, Inc	0.28%
Sumitomo Mitsui Trust Group Inc	0.28%
Bank of America Corp	0.28%
Citadel Advisors Llc	0.26%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Burning Rock Biotech Ltd — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.